Exchange Traded Funds (ETFs) are a relatively new financial product that has experienced significant growth in the last few years. Leveraged, inverse, and inverse leveraged ETFs—new ETF structures that have become available over the last several years—have recently become the target of regulatory investigations and litigation. This article provides an introduction to ETFs in the context of recent regulatory problems and litigation.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...